Radically changing ALS, together
Target ALS (targetals.org) scores 78 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Non-profit brands, in the 60th percentile of 13662 Healthcare brands.
Target ALS is a nonprofit organization based in New York, United States, dedicated to accelerating research into ALS (amyotrophic lateral sclerosis) and removing barriers to treatment discovery. It operates a collaborative 'Innovation Ecosystem' that connects scientists from academia and industry, promoting open sharing of high-quality research data. Its work is aimed at ALS patients and families, researchers, scientists, and donors, with the goal of speeding treatment development beyond what traditional research models allow.
| Brand Name | Target ALS |
|---|---|
| Domain | targetals.org |
| Industry | Healthcare, Non-profit |
| Headquarters | New York, United States |
| Main Competitors | ALS Association (76/100), ALS Therapy Development Institute (86/100), Answer ALS (70/100), Project MinE (79/100), I AM ALS (80/100) |
Moz Domain Authority 44/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #3,642,853 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "We’re radically changing the present and future of ALS." (Meta description: 9 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on Facebook, Instagram, X (Twitter), LinkedIn, YouTube; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Target ALS?", Claude could identify the brand as of October 2026. Target ALS is a nonprofit research foundation that funds and coordinates collaborative scientific research aimed at discovering treatments for ALS (amyotrophic lateral sclerosis). It works by connecting academic labs, biotech and pharmaceutical companies, and research consortia t Best known for Funding and coordinating collaborative, multi-institution ALS research to speed up therapeutic discovery.
When asked "Best brands similar to Target ALS?", Claude would recommend Target ALS as of October 2026. It's a well-regarded nonprofit in the ALS research funding space, often mentioned alongside groups like the ALS Association when discussing organizations driving ALS treatment research.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Target ALS's main competitors in Healthcare: ALS Association (76/100), ALS Therapy Development Institute (86/100), Answer ALS (70/100), Project MinE (79/100), I AM ALS (80/100).
Sources: Brand Analyzer scan
Target ALS is a nonprofit organization headquartered in New York, United States, focused on accelerating research into ALS (amyotrophic lateral sclerosis). It operates within the healthcare and non-profit sectors, working to speed up the discovery of viable treatments for the disease.
Sources: Target ALS official site
Target ALS has limited AI-search visibility, scoring 33/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 40, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Target ALS official site
Target ALS accelerates ALS research by building a collaborative 'Innovation Ecosystem' that unites scientists from academia and industry. It facilitates the generation and open sharing of high-quality research data, aiming to remove institutional and procedural barriers that typically slow down the discovery and development of ALS treatments.
Sources: Target ALS official site
Target ALS does not sell commercial products; as a nonprofit, it offers research infrastructure and support services, including funding and coordination for collaborative ALS research, a shared 'Innovation Ecosystem' connecting academic and industry scientists, and mechanisms for freely sharing high-quality research data to speed treatment discovery.
Sources: Target ALS official site
Target ALS scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Target ALS official site
Target ALS is known for pioneering a collaborative research model in the ALS field that unites academic and industry scientists to generate and freely share high-quality data, positioning itself as a faster, less siloed alternative to traditional research approaches.
Sources: Target ALS official site
Target ALS can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Target ALS official site
Target ALS serves ALS patients and their families, medical researchers and scientists working on ALS treatments, and donors who support efforts to accelerate a cure for the disease.
Sources: Target ALS official site
Target ALS scores 33/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Target ALS has a weak AI-visibility profile at 33/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,642,853 (Tranco) and a Moz Domain Authority of 44/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Target ALS from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Target ALS: TalkCampus (78/100), Syntra (78/100), Targeted Oncology (78/100), Technijian (78/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.